Skip to main content

Table 1 Pathological characteristics of the TG human breast tumors

From: Expression of Molecular Biomarkers in Primary Breast Tumors Implanted into a Surrogate Host: Increased Levels of Cyclins Correlate with Tumor Progression

Tissue

Agea

Estrogen Receptora,b

Tumor Typea

Gradec

Lymph Noded

Xenograft Growthe

144

72

Positive

Focal infiltrating ductal carcinoma with extensive intraductal component

G2.

N

+

111

74

n.d.

Tubular and ductal carcinoma

G3

Y

+

037

76

Positive

Infiltrating mammary carcinoma with features of variant lobular carcinoma

G2

N

+

202

84

85

Infiltrating adenocarcinoma

G2/G3

N

+

195

84

85

Invasive ductal carcinoma

G2

Y

+

432

85

Negative

Residual invasive ductal carcinoma

G3

N

+

118

34

n.d.

Invasive carcinoma

G3

n.d.

003

40

10

Invasive ductal carcinoma

G3

N

089

48

Negative

Invasive ductal carcinoma

G3

Y

062

48

n.d.

Poorly differentiated infiltrating ductal carcinoma

Gl

Y

075

53

n.d.

Infiltrating ductal carcinoma

G2

Y

222

58

Negative

Invasive carcinoma

G2

Y

148

64

73

Invasive and ductal carcinoma

G2/G3

N

198

71

72

Invasive adenocarcinoma

Gl

N

337

85

85

Infiltrating ductal carcinoma

G3

Y

155

89

Positive

Infiltrating ductal carcinoma

G2

Y

  1. aThis information was obtained from surgical and pathological records from each case and was supplied anonymously by the Ohio State University Tissue Procurement Service.
  2. bEstrogen receptor values (% positive).
  3. cGrade = tubule formation, nuclear pleomorphism, mitotic scores.
  4. dLymph node = indication of metastatic malignancy in lymph node.
  5. eXenograft growth was positive (+) when a nodule at the site of the transplant was visible within 2 weeks. Growth was negative (—) when the tumor was absorbed by the host.
  6. n.d., not determined or no information available.